US Broker Ratings

Regeneron Pharmaceuticals, Inc. (REGN): Investor Outlook Reveals 23.5% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a leading player in the biotechnology industry with a market capitalization of $61.52 billion, is capturing the attention of investors with its robust pipeline and..

Moderna, Inc. (MRNA) Stock Analysis: Potential 62.74% Upside Despite Challenges in Revenue Growth

Investors eyeing the biotechnology sector may find Moderna, Inc. (NASDAQ: MRNA) a compelling yet complex proposition. With a market capitalization of $10.9 billion, this Cambridge, Massachusetts-based company has made significant..

Agilent Technologies, Inc. (A) Stock Analysis: Navigating a Promising 15.41% Upside in the Healthcare Sector

Agilent Technologies, Inc. (NYSE: A) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $33.86 billion, Agilent is..

Waters Corporation (WAT): Investor Outlook Reveals a Strong 20.13% Upside Potential

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, specializes in diagnostics and research. Based in the United States, this company boasts a market cap of $17.35 billion,..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Discover a 27.4% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $3.2..

Lantheus Holdings, Inc. (LNTH): Investor Outlook with a 67% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH), a key player in the healthcare sector, is drawing significant attention from investors due to its robust diagnostic and therapeutic product portfolio. Specializing in the..

Baxter International Inc. (BAX): Investor Outlook with a 21.41% Potential Upside

Baxter International Inc. (NYSE: BAX) stands as a significant player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $12.42 billion, this Deerfield, Illinois-based..

ADMA Biologics Inc (ADMA) Stock Analysis: 71% Potential Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology industry, is capturing investor attention with its substantial growth potential and strategic market positioning. With a market capitalization of..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Strong Buy Ratings Signal Potential Upside of Nearly 32%

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the healthcare sector specializing in both specialty and generic drug manufacturing, is catching the eye of investors with a notable potential..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating a Stable Course in Medical Distribution

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a market capitalization of $8.23 billion, this U.S.-based company..

Verona Pharma plc (VRNA) Investor Outlook: Navigating a High-Stakes Biotech with a $8.95 Billion Market Cap

Verona Pharma plc (NASDAQ: VRNA) is captivating investor attention with its robust market capitalization of $8.95 billion in the biotech sector, a testament to its promising pipeline in the healthcare..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Potential Amidst Challenging Metrics

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $7.71 billion,..

Danaher Corporation (DHR) Stock Analysis: A 16.6% Upside Potential Amidst Robust Analyst Consensus

For those keeping a close eye on the healthcare sector, Danaher Corporation (NYSE: DHR) presents a compelling opportunity with significant growth potential. With a market capitalization of $151.04 billion, Danaher..

Tempus AI, Inc. (TEM) Investor Outlook: Navigating a Biotech Powerhouse with 89.6% Revenue Growth

Tempus AI, Inc. (NASDAQ: TEM) has been capturing investor attention with its impressive strides in the healthcare technology sector. With a market capitalization of $12.82 billion, this Chicago-based company is..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Potential 104% Upside in Biotech Innovation

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its compelling growth prospects and analyst optimism. As a biopharmaceutical..

Globus Medical, Inc. (GMED): Analyst Ratings Suggest a 36.28% Upside for Investors

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors. The company, with a market capitalization..

Genmab A/S (GMAB) Stock Analysis: Uncovering a 31% Potential Upside in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, Genmab A/S (NASDAQ: GMAB) presents a compelling case. Headquartered in Copenhagen, Denmark, this biotech powerhouse has carved a niche in developing antibody-based..

Regencell Bioscience Holdings (RGC): A Unique Play in Healthcare with Intriguing Technicals

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands as a distinctive entity in the healthcare sector, operating within the niche of Traditional Chinese Medicine (TCM) for neurocognitive disorders. Based in Hong..

Elanco Animal Health (ELAN): Stock Analysis Shows Modest Upside Amidst Strong Product Portfolio

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a significant player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic animal health products. With..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with a 44% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) has emerged as a significant player in the biotechnology sector, presenting intriguing prospects for investors. Based in Morrisville, North Carolina, the company focuses on developing..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds